Proactive Investors - Run By Investors For Investors

Auxly Cannabis acquires cannabis-focused Canadian research group KGK Science

KGK has expanded its research capabilities to include cannabinoid and animal products
Cannabis plants
Auxly Cannabis Group is a collective of entrepreneurs in the cannabis industry

Auxly Cannabis Group Inc (TSX-V:XLY) said on Tuesday it forged a share purchase agreement with KGK Science Inc to acquire all of its shares for US$12.3mln.

KGK is a leading health and wellness-focused private contract research organization based in London, Ontario. The company expects to leverage KGK’s expertise and research abilities to boost its product development efforts through collaboration with Auxly's wholly owned subsidiary, Dosecann Inc. 

For nearly two decades, KGK has served many of North America’s leading nutraceutical, natural health product and consumer packaged goods companies such as Kraft Foods, Sanofi, Nature’s Bounty, and NuSkin.

KGK works with their clients in substantiating claims for their products through randomized clinical trials in addition to providing other research services such as participant recruitment, regulatory compliance solutions, research support services and consulting.

Along with KGK’s involvement in the health and wellness space, KGK has expanded their research capabilities to include cannabinoid and animal products in recent years.

Auxly Cannabis Group is a collective of entrepreneurs in the cannabis industry. The company is based in Vancouver, Canada.

Its shares were recently up 2.3% to CC$0.89 in Toronto.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full XLY profile View Profile

Auxly Cannabis Group Inc Timeline

Related Articles

cannabis plant
May 05 2019
The cannabis company invests in income-producing property and provides financing solutions and capital investment to service the blossoming cannabis industry
November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use